位置:首页 > 蛋白库 > ETFA_HUMAN
ETFA_HUMAN
ID   ETFA_HUMAN              Reviewed;         333 AA.
AC   P13804; B4DT43; Q53XN3;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1990, sequence version 1.
DT   03-AUG-2022, entry version 225.
DE   RecName: Full=Electron transfer flavoprotein subunit alpha, mitochondrial;
DE            Short=Alpha-ETF;
DE   Flags: Precursor;
GN   Name=ETFA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=3170610; DOI=10.1016/s0021-9258(19)37655-0;
RA   Finocchiaro G., Ito M., Ikeda Y., Tanaka K.;
RT   "Molecular cloning and nucleotide sequence of cDNAs encoding the alpha-
RT   subunit of human electron transfer flavoprotein.";
RL   J. Biol. Chem. 263:15773-15780(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], ALTERNATIVE SPLICING, FUNCTION, AND
RP   VARIANT GA2A MET-266.
RX   PubMed=12815589; DOI=10.1002/humu.10226;
RA   Olsen R.K.J., Andresen B.S., Christensen E., Bross P., Skovby F.,
RA   Gregersen N.;
RT   "Clear relationship between ETF/ETFDH genotype and phenotype in patients
RT   with multiple acyl-CoA dehydrogenation deficiency.";
RL   Hum. Mutat. 22:12-23(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R., Fahey J.,
RA   Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G., Johnson E.,
RA   Jones C., Kamat A., Kaur A., Locke D.P., Madan A., Munson G., Jaffe D.B.,
RA   Lui A., Macdonald P., Mauceli E., Naylor J.W., Nesbitt R., Nicol R.,
RA   O'Leary S.B., Ratcliffe A., Rounsley S., She X., Sneddon K.M.B.,
RA   Stewart S., Sougnez C., Stone S.M., Topham K., Vincent D., Wang S.,
RA   Zimmer A.R., Birren B.W., Hood L., Lander E.S., Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human chromosome
RT   15.";
RL   Nature 440:671-675(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Chondrosarcoma, and Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 86-101 AND 170-203, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [9]
RP   REVIEW.
RX   PubMed=17941859; DOI=10.1111/j.1742-4658.2007.06107.x;
RA   Toogood H.S., Leys D., Scrutton N.S.;
RT   "Dynamics driving function: new insights from electron transferring
RT   flavoproteins and partner complexes.";
RL   FEBS J. 274:5481-5504(2007).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-140, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   CLEAVAGE OF TRANSIT PEPTIDE [LARGE SCALE ANALYSIS] AFTER PHE-19, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [14]
RP   FUNCTION, INTERACTION WITH ETFRF1, AND IDENTIFICATION IN A COMPLEX WITH
RP   ETFB AND ETFRF1.
RX   PubMed=27499296; DOI=10.1016/j.molcel.2016.06.033;
RA   Floyd B.J., Wilkerson E.M., Veling M.T., Minogue C.E., Xia C., Beebe E.T.,
RA   Wrobel R.L., Cho H., Kremer L.S., Alston C.L., Gromek K.A., Dolan B.K.,
RA   Ulbrich A., Stefely J.A., Bohl S.L., Werner K.M., Jochem A.,
RA   Westphall M.S., Rensvold J.W., Taylor R.W., Prokisch H., Kim J.J.,
RA   Coon J.J., Pagliarini D.J.;
RT   "Mitochondrial protein interaction mapping identifies regulators of
RT   respiratory chain function.";
RL   Mol. Cell 63:621-632(2016).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 20-333 IN COMPLEX WITH FAD AND
RP   ETFB, SUBUNIT, COFACTOR, AND DOMAIN.
RX   PubMed=8962055; DOI=10.1073/pnas.93.25.14355;
RA   Roberts D.L., Frerman F.E., Kim J.-J.P.;
RT   "Three-dimensional structure of human electron transfer flavoprotein to
RT   2.1-A resolution.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:14355-14360(1996).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) IN COMPLEX WITH ETFB AND ACADM,
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=15159392; DOI=10.1074/jbc.m404884200;
RA   Toogood H.S., van Thiel A., Basran J., Sutcliffe M.J., Scrutton N.S.,
RA   Leys D.;
RT   "Extensive domain motion and electron transfer in the human electron
RT   transferring flavoprotein.medium chain acyl-CoA dehydrogenase complex.";
RL   J. Biol. Chem. 279:32904-32912(2004).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.11 ANGSTROMS) IN COMPLEX WITH FAD; ETFB AND ACADM,
RP   FUNCTION, COFACTOR, AND MUTAGENESIS OF ARG-249.
RX   PubMed=15975918; DOI=10.1074/jbc.m505562200;
RA   Toogood H.S., van Thiel A., Scrutton N.S., Leys D.;
RT   "Stabilization of non-productive conformations underpins rapid electron
RT   transfer to electron-transferring flavoprotein.";
RL   J. Biol. Chem. 280:30361-30366(2005).
RN   [18]
RP   VARIANT GA2A GLY-157, AND FUNCTION.
RX   PubMed=1882842;
RA   Indo Y., Glassberg R., Yokota I., Tanaka K.;
RT   "Molecular characterization of variant alpha-subunit of electron transfer
RT   flavoprotein in three patients with glutaric acidemia type II -- and
RT   identification of glycine substitution for valine-157 in the sequence of
RT   the precursor, producing an unstable mature protein in a patient.";
RL   Am. J. Hum. Genet. 49:575-580(1991).
RN   [19]
RP   VARIANTS GA2A ARG-116 AND MET-266, FUNCTION, AND CHARACTERIZATION OF
RP   VARIANT GA2A MET-266.
RX   PubMed=1430199; DOI=10.1172/jci116040;
RA   Freneaux E., Sheffield V.C., Molin L., Shires A., Rhead W.;
RT   "Glutaric acidemia type II. Heterogeneity in beta-oxidation flux,
RT   polypeptide synthesis, and complementary DNA mutations in the alpha subunit
RT   of electron transfer flavoprotein in eight patients.";
RL   J. Clin. Invest. 90:1679-1686(1992).
RN   [20]
RP   CHARACTERIZATION OF VARIANTS GA2A ARG-116 AND MET-266, FUNCTION, COFACTOR,
RP   AND SUBUNIT.
RX   PubMed=9334218; DOI=10.1074/jbc.272.42.26425;
RA   Salazar D., Zhang L., deGala G.D., Frerman F.E.;
RT   "Expression and characterization of two pathogenic mutations in human
RT   electron transfer flavoprotein.";
RL   J. Biol. Chem. 272:26425-26433(1997).
RN   [21]
RP   VARIANT ILE-171, CHARACTERIZATION OF VARIANT ILE-171, AND FUNCTION.
RX   PubMed=10356313; DOI=10.1006/mgme.1999.2856;
RA   Bross P., Pedersen P., Winter V., Nyholm M., Johansen B.N., Olsen R.K.,
RA   Corydon M.J., Andresen B.S., Eiberg H., Kolvraa S., Gregersen N.;
RT   "A polymorphic variant in the human electron transfer flavoprotein alpha-
RT   chain (alpha-T171) displays decreased thermal stability and is
RT   overrepresented in very-long-chain acyl-CoA dehydrogenase-deficient
RT   patients with mild childhood presentation.";
RL   Mol. Genet. Metab. 67:138-147(1999).
CC   -!- FUNCTION: Heterodimeric electron transfer flavoprotein that accepts
CC       electrons from several mitochondrial dehydrogenases, including acyl-CoA
CC       dehydrogenases, glutaryl-CoA and sarcosine dehydrogenase
CC       (PubMed:27499296, PubMed:15159392, PubMed:15975918, PubMed:9334218,
CC       PubMed:10356313). It transfers the electrons to the main mitochondrial
CC       respiratory chain via ETF-ubiquinone oxidoreductase (ETF dehydrogenase)
CC       (PubMed:9334218). Required for normal mitochondrial fatty acid
CC       oxidation and normal amino acid metabolism (PubMed:12815589,
CC       PubMed:1882842, PubMed:1430199). {ECO:0000269|PubMed:10356313,
CC       ECO:0000269|PubMed:12815589, ECO:0000269|PubMed:1430199,
CC       ECO:0000269|PubMed:15159392, ECO:0000269|PubMed:15975918,
CC       ECO:0000269|PubMed:27499296, ECO:0000269|PubMed:9334218,
CC       ECO:0000303|PubMed:17941859, ECO:0000305|PubMed:1882842}.
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:15975918, ECO:0000269|PubMed:8962055,
CC         ECO:0000269|PubMed:9334218};
CC       Note=Binds 1 FAD per dimer. {ECO:0000269|PubMed:15975918,
CC       ECO:0000269|PubMed:8962055};
CC   -!- SUBUNIT: Heterodimer composed of ETFA and ETFB (PubMed:8962055,
CC       PubMed:15159392, PubMed:15975918, PubMed:9334218). Identified in a
CC       complex that contains ETFA, ETFB and ETFRF1 (PubMed:27499296).
CC       Interaction with ETFRF1 promotes dissociation of the bound FAD and loss
CC       of electron transfer activity (PubMed:27499296). Interacts with TASOR
CC       (By similarity). {ECO:0000250|UniProtKB:Q99LC5,
CC       ECO:0000269|PubMed:15159392, ECO:0000269|PubMed:15975918,
CC       ECO:0000269|PubMed:27499296, ECO:0000269|PubMed:8962055}.
CC   -!- INTERACTION:
CC       P13804; P38117: ETFB; NbExp=2; IntAct=EBI-1052886, EBI-1056543;
CC       P13804; Q8IWL3: HSCB; NbExp=3; IntAct=EBI-1052886, EBI-1805738;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P13804-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P13804-2; Sequence=VSP_043246;
CC   -!- DOMAIN: Domain I shares an identical polypeptide fold with the beta
CC       subunit ETFB though there is no sequence similarity.
CC       {ECO:0000269|PubMed:8962055}.
CC   -!- PTM: The N-terminus is blocked.
CC   -!- DISEASE: Glutaric aciduria 2A (GA2A) [MIM:231680]: An autosomal
CC       recessively inherited disorder of fatty acid, amino acid, and choline
CC       metabolism. It is characterized by multiple acyl-CoA dehydrogenase
CC       deficiencies resulting in large excretion not only of glutaric acid,
CC       but also of lactic, ethylmalonic, butyric, isobutyric, 2-methyl-
CC       butyric, and isovaleric acids. {ECO:0000269|PubMed:12815589,
CC       ECO:0000269|PubMed:1430199, ECO:0000269|PubMed:1882842,
CC       ECO:0000269|PubMed:9334218}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the ETF alpha-subunit/FixB family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J04058; AAA52406.1; -; mRNA.
DR   EMBL; S55815; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; S55816; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AJ224002; CAA11802.1; -; Genomic_DNA.
DR   EMBL; AF436657; AAN03712.1; -; Genomic_DNA.
DR   EMBL; AF436646; AAN03712.1; JOINED; Genomic_DNA.
DR   EMBL; AF436647; AAN03712.1; JOINED; Genomic_DNA.
DR   EMBL; AF436648; AAN03712.1; JOINED; Genomic_DNA.
DR   EMBL; AF436649; AAN03712.1; JOINED; Genomic_DNA.
DR   EMBL; AF436650; AAN03712.1; JOINED; Genomic_DNA.
DR   EMBL; AF436651; AAN03712.1; JOINED; Genomic_DNA.
DR   EMBL; AF436652; AAN03712.1; JOINED; Genomic_DNA.
DR   EMBL; AF436653; AAN03712.1; JOINED; Genomic_DNA.
DR   EMBL; AF436654; AAN03712.1; JOINED; Genomic_DNA.
DR   EMBL; AF436655; AAN03712.1; JOINED; Genomic_DNA.
DR   EMBL; AF436656; AAN03712.1; JOINED; Genomic_DNA.
DR   EMBL; BT009796; AAP88798.1; -; mRNA.
DR   EMBL; AK292979; BAF85668.1; -; mRNA.
DR   EMBL; AK300044; BAG61855.1; -; mRNA.
DR   EMBL; AC027243; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC091100; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471136; EAW99221.1; -; Genomic_DNA.
DR   EMBL; BC015526; AAH15526.1; -; mRNA.
DR   EMBL; BC095457; AAH95457.1; -; mRNA.
DR   CCDS; CCDS32299.1; -. [P13804-1]
DR   CCDS; CCDS45311.1; -. [P13804-2]
DR   PIR; A31998; A31998.
DR   RefSeq; NP_000117.1; NM_000126.3. [P13804-1]
DR   RefSeq; NP_001121188.1; NM_001127716.1. [P13804-2]
DR   PDB; 1EFV; X-ray; 2.10 A; A=20-333.
DR   PDB; 1T9G; X-ray; 2.90 A; R=1-333.
DR   PDB; 2A1T; X-ray; 2.80 A; R=1-333.
DR   PDB; 2A1U; X-ray; 2.11 A; A=1-333.
DR   PDBsum; 1EFV; -.
DR   PDBsum; 1T9G; -.
DR   PDBsum; 2A1T; -.
DR   PDBsum; 2A1U; -.
DR   AlphaFoldDB; P13804; -.
DR   SMR; P13804; -.
DR   BioGRID; 108409; 248.
DR   ComplexPortal; CPX-2731; Mitochondrial electron transfer flavoprotein complex.
DR   DIP; DIP-6161N; -.
DR   IntAct; P13804; 73.
DR   MINT; P13804; -.
DR   STRING; 9606.ENSP00000452762; -.
DR   CarbonylDB; P13804; -.
DR   GlyGen; P13804; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P13804; -.
DR   MetOSite; P13804; -.
DR   PhosphoSitePlus; P13804; -.
DR   SwissPalm; P13804; -.
DR   BioMuta; ETFA; -.
DR   DMDM; 119636; -.
DR   UCD-2DPAGE; P13804; -.
DR   CPTAC; CPTAC-365; -.
DR   CPTAC; CPTAC-366; -.
DR   EPD; P13804; -.
DR   jPOST; P13804; -.
DR   MassIVE; P13804; -.
DR   MaxQB; P13804; -.
DR   PaxDb; P13804; -.
DR   PeptideAtlas; P13804; -.
DR   PRIDE; P13804; -.
DR   ProteomicsDB; 52989; -. [P13804-1]
DR   ProteomicsDB; 52990; -. [P13804-2]
DR   TopDownProteomics; P13804-1; -. [P13804-1]
DR   TopDownProteomics; P13804-2; -. [P13804-2]
DR   Antibodypedia; 14895; 375 antibodies from 33 providers.
DR   DNASU; 2108; -.
DR   Ensembl; ENST00000433983.6; ENSP00000399273.2; ENSG00000140374.17. [P13804-2]
DR   Ensembl; ENST00000557943.6; ENSP00000452762.1; ENSG00000140374.17. [P13804-1]
DR   Ensembl; ENST00000690610.1; ENSP00000510473.1; ENSG00000140374.17. [P13804-1]
DR   GeneID; 2108; -.
DR   KEGG; hsa:2108; -.
DR   MANE-Select; ENST00000557943.6; ENSP00000452762.1; NM_000126.4; NP_000117.1.
DR   UCSC; uc002bbt.3; human. [P13804-1]
DR   CTD; 2108; -.
DR   DisGeNET; 2108; -.
DR   GeneCards; ETFA; -.
DR   GeneReviews; ETFA; -.
DR   HGNC; HGNC:3481; ETFA.
DR   HPA; ENSG00000140374; Tissue enhanced (liver, tongue).
DR   MalaCards; ETFA; -.
DR   MIM; 231680; phenotype.
DR   MIM; 608053; gene.
DR   neXtProt; NX_P13804; -.
DR   OpenTargets; ENSG00000140374; -.
DR   Orphanet; 394532; Multiple acyl-CoA dehydrogenase deficiency, mild type.
DR   Orphanet; 394529; Multiple acyl-CoA dehydrogenase deficiency, severe neonatal type.
DR   PharmGKB; PA27897; -.
DR   VEuPathDB; HostDB:ENSG00000140374; -.
DR   eggNOG; KOG3954; Eukaryota.
DR   GeneTree; ENSGT00390000013422; -.
DR   HOGENOM; CLU_034178_0_0_1; -.
DR   InParanoid; P13804; -.
DR   OMA; WRPYAEQ; -.
DR   PhylomeDB; P13804; -.
DR   TreeFam; TF105763; -.
DR   PathwayCommons; P13804; -.
DR   Reactome; R-HSA-611105; Respiratory electron transport.
DR   SignaLink; P13804; -.
DR   BioGRID-ORCS; 2108; 10 hits in 1085 CRISPR screens.
DR   ChiTaRS; ETFA; human.
DR   EvolutionaryTrace; P13804; -.
DR   GeneWiki; ETFA; -.
DR   GenomeRNAi; 2108; -.
DR   Pharos; P13804; Tbio.
DR   PRO; PR:P13804; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   RNAct; P13804; protein.
DR   Bgee; ENSG00000140374; Expressed in oocyte and 205 other tissues.
DR   ExpressionAtlas; P13804; baseline and differential.
DR   Genevisible; P13804; HS.
DR   GO; GO:0045251; C:electron transfer flavoprotein complex; IPI:ComplexPortal.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0009055; F:electron transfer activity; IDA:UniProtKB.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IDA:UniProtKB.
DR   GO; GO:0016491; F:oxidoreductase activity; IDA:UniProtKB.
DR   GO; GO:0009063; P:cellular amino acid catabolic process; IDA:ComplexPortal.
DR   GO; GO:0033539; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; IDA:UniProtKB.
DR   GO; GO:0022904; P:respiratory electron transport chain; IDA:ComplexPortal.
DR   CDD; cd01715; ETF_alpha; 1.
DR   Gene3D; 3.40.50.620; -; 1.
DR   InterPro; IPR029035; DHS-like_NAD/FAD-binding_dom.
DR   InterPro; IPR014730; ETF_a/b_N.
DR   InterPro; IPR001308; ETF_a/FixB.
DR   InterPro; IPR033947; ETF_alpha_N.
DR   InterPro; IPR014731; ETF_asu_C.
DR   InterPro; IPR018206; ETF_asu_C_CS.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   PANTHER; PTHR43153; PTHR43153; 1.
DR   Pfam; PF01012; ETF; 1.
DR   Pfam; PF00766; ETF_alpha; 1.
DR   PIRSF; PIRSF000089; Electra_flavoP_a; 1.
DR   SMART; SM00893; ETF; 1.
DR   SUPFAM; SSF52467; SSF52467; 1.
DR   PROSITE; PS00696; ETF_ALPHA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Direct protein sequencing;
KW   Disease variant; Electron transport; FAD; Flavoprotein; Glutaricaciduria;
KW   Mitochondrion; Phosphoprotein; Reference proteome; Transit peptide;
KW   Transport.
FT   TRANSIT         1..19
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000255, ECO:0007744|PubMed:25944712"
FT   CHAIN           20..333
FT                   /note="Electron transfer flavoprotein subunit alpha,
FT                   mitochondrial"
FT                   /id="PRO_0000008650"
FT   REGION          20..204
FT                   /note="Domain I"
FT                   /evidence="ECO:0000269|PubMed:8962055"
FT   REGION          205..333
FT                   /note="Domain II"
FT                   /evidence="ECO:0000269|PubMed:8962055"
FT   BINDING         223
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000269|PubMed:15975918,
FT                   ECO:0000269|PubMed:8962055, ECO:0007744|PDB:1EFV,
FT                   ECO:0007744|PDB:2A1T"
FT   BINDING         248
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000269|PubMed:15975918,
FT                   ECO:0000269|PubMed:8962055, ECO:0007744|PDB:1EFV,
FT                   ECO:0007744|PDB:2A1T"
FT   BINDING         263..266
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000269|PubMed:15975918,
FT                   ECO:0000269|PubMed:8962055, ECO:0007744|PDB:1EFV,
FT                   ECO:0007744|PDB:2A1T"
FT   BINDING         281..286
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000269|PubMed:15975918,
FT                   ECO:0000269|PubMed:8962055, ECO:0007744|PDB:1EFV,
FT                   ECO:0007744|PDB:2A1T"
FT   BINDING         300
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000269|PubMed:15975918,
FT                   ECO:0000269|PubMed:8962055, ECO:0007744|PDB:1EFV,
FT                   ECO:0007744|PDB:2A1T"
FT   BINDING         318..319
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000269|PubMed:15975918,
FT                   ECO:0000269|PubMed:8962055, ECO:0007744|PDB:1EFV,
FT                   ECO:0007744|PDB:2A1T"
FT   MOD_RES         59
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   MOD_RES         59
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   MOD_RES         62
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   MOD_RES         69
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   MOD_RES         69
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   MOD_RES         75
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   MOD_RES         85
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   MOD_RES         85
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   MOD_RES         93
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   MOD_RES         101
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   MOD_RES         139
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   MOD_RES         140
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         158
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   MOD_RES         158
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   MOD_RES         164
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   MOD_RES         187
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   MOD_RES         203
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   MOD_RES         203
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   MOD_RES         216
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   MOD_RES         226
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   MOD_RES         226
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   MOD_RES         232
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   MOD_RES         232
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   MOD_RES         301
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   VAR_SEQ         14..62
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_043246"
FT   VARIANT         116
FT                   /note="G -> R (in GA2A; impaired protein stability and loss
FT                   of electron transfer activity; dbSNP:rs119458971)"
FT                   /evidence="ECO:0000269|PubMed:1430199,
FT                   ECO:0000269|PubMed:9334218"
FT                   /id="VAR_002366"
FT   VARIANT         157
FT                   /note="V -> G (in GA2A; dbSNP:rs119458969)"
FT                   /evidence="ECO:0000269|PubMed:1882842"
FT                   /id="VAR_002367"
FT   VARIANT         171
FT                   /note="T -> I (decreased protein stability;
FT                   dbSNP:rs1801591)"
FT                   /evidence="ECO:0000269|PubMed:10356313"
FT                   /id="VAR_008547"
FT   VARIANT         266
FT                   /note="T -> M (in GA2A; decreased electron transfer
FT                   activity; dbSNP:rs119458970)"
FT                   /evidence="ECO:0000269|PubMed:12815589,
FT                   ECO:0000269|PubMed:1430199"
FT                   /id="VAR_002368"
FT   MUTAGEN         249
FT                   /note="R->A: Loss of electron transfer activity."
FT                   /evidence="ECO:0000269|PubMed:15975918"
FT   STRAND          21..25
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   STRAND          28..31
FT                   /evidence="ECO:0007829|PDB:2A1U"
FT   HELIX           36..45
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   STRAND          49..58
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   HELIX           61..69
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   STRAND          75..80
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   HELIX           82..84
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   HELIX           89..103
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   STRAND          106..113
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   HELIX           114..127
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   STRAND          132..135
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   STRAND          137..140
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   STRAND          143..148
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   TURN            149..152
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   STRAND          153..159
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   STRAND          162..168
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   HELIX           170..172
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   STRAND          178..180
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   STRAND          184..187
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   STRAND          196..204
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   HELIX           212..214
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   STRAND          216..221
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   HELIX           223..225
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   HELIX           229..231
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   HELIX           232..241
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   STRAND          244..247
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   HELIX           249..253
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   HELIX           259..261
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   STRAND          262..264
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   STRAND          273..279
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   HELIX           284..287
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   TURN            288..292
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   STRAND          294..301
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   HELIX           306..309
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   STRAND          312..317
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   HELIX           319..329
FT                   /evidence="ECO:0007829|PDB:1EFV"
SQ   SEQUENCE   333 AA;  35080 MW;  2EC6D1ADE68CBDB5 CRC64;
     MFRAAAPGQL RRAASLLRFQ STLVIAEHAN DSLAPITLNT ITAATRLGGE VSCLVAGTKC
     DKVAQDLCKV AGIAKVLVAQ HDVYKGLLPE ELTPLILATQ KQFNYTHICA GASAFGKNLL
     PRVAAKLEVA PISDIIAIKS PDTFVRTIYA GNALCTVKCD EKVKVFSVRG TSFDAAATSG
     GSASSEKASS TSPVEISEWL DQKLTKSDRP ELTGAKVVVS GGRGLKSGEN FKLLYDLADQ
     LHAAVGASRA AVDAGFVPND MQVGQTGKIV APELYIAVGI SGAIQHLAGM KDSKTIVAIN
     KDPEAPIFQV ADYGIVADLF KVVPEMTEIL KKK
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024